Eli Lilly is trading 3.27% up at $1,312.29 after coverage linked the rise to its October 22, 2026, groundbreaking on a $5 billion manufacturing facility in Goochland County, Virginia.
- The site will produce cancer medicines and create 650 jobs.
- Shares rose against a broadly weaker market; healthcare also advanced, providing additional sector support.